Stereotaxis terminates $15M at-the-market equity offering with Cantor Stereotaxis canceled its $15M at-the-market equity offering with Cantor Fitzgerald dated November 27, 2013. . The company did not sell any shares.
Stereotaxis and Philips sign addendum to their agreement Stereotaxis announced Stereotaxis and Philips have signed an addendum pursuant to their existing Development and Cooperation Agreement to facilitate development of a new interface between each company's most advanced systems for electrophysiology and interventional cardiology procedures. The new interface will enable interoperability of Stereotaxis' Niobe ES remote magnetic navigation system with the latest version of Philips' cardiovascular X-ray system, Allura Xper FD10. This new interface is expected to be available in major global markets in 2016.